ASSOCIATION BETWEEN DIABETIC RETINOPATHY AND PROTEINURIA IN PATIENTS WITH TYPE II DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL, QUETTA
Main Article Content
Keywords
Diabetic Retinopathy; Proteinuria; Type‑II Diabetes Mellitus; Microvascular Complications; Pakistan
Abstract
Background: Diabetic Retinopathy (DR) and proteinuria are major microvascular complications of Type‑II Diabetes Mellitus (T2DM). Their coexistence may reflect widespread systemic vascular damage, yet data from South Asia remain scarce. Diabetic retinopathy (DR) is a major complication of diabetes and the leading cause of decreased vision in working-age people (1). It is anticipated that the prevalence of DR is likely to continue to rise, particularly in Asia and other developing areas.
Objective: To determine the frequency of DR and assess its association with proteinuria among T2DM patients at a tertiary care hospital in Quetta, Pakistan. To compare the frequency of diabetic retinopathy with proteinuria in patients presenting with type-II diabetes mellitus, at a tertiary care hospital, Quetta.
Methods: A cross‑sectional study involving 228 T2DM patients who fulfilled the inclusion criteria and visited to Sandeman Provincial Hospital, Quetta were included in the study after taken informed consent. Urinary collection was done to check proteinuria, and fundoscopy was done to check the diabetic retinopathy. All the collected data were entered into the proforma attached at the end and used electronically for research purpose.
Results: DR was diagnosed by direct fundoscopy; proteinuria (>0.5 g/24 h) was measured using 24‑hour urine collection. Data were analyzed in SPSS v22; p < 0.05 was considered significant. The mean age was 52.7 ± 11.9 years; 57% were male. DR prevalence was 19.7% (45/228). DR occurred in 26/228 (11.4%) patients with proteinuria and 19/228 (8.3%) without proteinuria (χ², p = 0.0001). Mean ± SD of age was 52.7±11.9 years. In distribution of gender, 130 (57.0%) were male while 98 (43.0%) were female. Diabetes retinopathy was found to be in 45 (19.7%) patients. Diabetic retinopathy was noted in 26 (11.4%) patients with proteinuria while 19 (8.3%) without proteinuria and P-value found to be highly significant i.e., P=0.0001.
Conclusion: Proteinuria is significantly associated with DR in T2DM patients. Integrated renal and ocular screening is recommended in routine diabetes care.
References
2. Haghighatpanah M, et al. Correlation of HbA1c with fasting and postprandial glucose. Int J Pharm Pharm Sci. 2016;8:285–8.
3. Rajagopal L, et al. Impact of iron deficiency anemia on HbA1c. Ann Pathol Lab Med. 2017; 4:A148–52.
4. Romero-Aroca P, et al. Diabetic macular edema pathophysiology. J Diabetes Res. 2016; 2016:2156273.
5. Wang W, Lo AC. Diabetic retinopathy: Pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816.
6. Sulaiman MK. Diabetic nephropathy advances. Diabetol Metab Syndr. 2019;11(1):7.
7. Rani PK, et al. Albuminuria and DR in T2DM (SN-DREAMS). Diabetol Metab Syndr. 2011;3(1):1–8.
8. Gall MA, et al. Micro/macroalbuminuria and DR prevalence in Europe. Diabetologia. 1991;34:655–61.
9. Mohan V, et al. Proteinuria frequency in T2DM, India. Postgrad Med J. 2000;76:569–73.
10. Eisma JH, et al. Insights from donor tissues on DR. World J Diabetes. 2015;6:312–20.
11. Hendrick AM, et al. Diabetic retinopathy. Prim Care. 2015;42:451–64.
12. Sayin N, et al. Ocular complications of DM. World J Diabetes. 2015;6:92–108.
13. Vieira-Potter VJ, et al. Therapeutic approaches to ocular complications. Biomed Res Int. 2016; 2016:3801570.
14. Khan A, et al. Visual complications beyond retinopathy. Diabet Med. 2017;34:478–84.
15. Nittala MG, et al. Risk factors for PDR in Latinos. Retina. 2014;34:1594–9.
16. Porta M, et al. EURODIAB: Progression to PDR. Diabetologia. 2001;44:2203–9.
17. Wang Y, et al. DR and DME prevalence and risk factors. Ophthalmic Res. 2020. [Epub ahead of print].
18. Manaviat MR, et al. Retinopathy & microalbuminuria link. BMC Ophthalmol. 2004;4:1–4.
19. Wild S, et al. Global diabetes prevalence to 2030. Diabetes Care. 2004;27:1047–53.
20. Stratton IM, et al. UKPDS 50: Risk factors for DR. Diabetologia. 2001;44:156–63.
21. Davis MD, et al. ETDRS report 18 – High-risk PDR. Invest Ophthalmol Vis Sci. 1998;39:233–52.
22. Tapp RJ, et al. DR prevalence in Australia. Diabetes Care. 2003;26:1731–7.
23. Klein R, et al. Wisconsin study of DR progression. Ophthalmology. 1998;105:1801–15.
24. Kohner EM, et al. DR at T2DM diagnosis (UKPDS 30). Arch Ophthalmol. 1998;116:297–303.
25. Jun M, et al. Albuminuria changes & outcomes (ADVANCE-ON). Diabetes Care. 2018;41:163–70.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Fazila Noor
General Physician, Medicine Unit II, Sandeman Provincial Hospital, Quetta, Pakistan
Dr. Rukhsar Hanif Shaikh
Women Medical Officer, Medical Unit I, Chandka Medical Hospital, Larkana, Pakistan
Dr. Hiba Sami
Consultant Physician, Medical Unit II, Sandeman Provincial Hospital, Quetta, Pakistan
Dr. Sassi Manzoor Hassan
Assistant Professor, Department of Medicine, Mekran Medical College, Turbat, Pakistan
Dr. Kapil Dev
FCPS Medicine, Dow University of Health Sciences, Karachi, Pakistan
Dr. Durdana Mohsin
Junior Registrar, Department of General Surgery, Jhalawan Medical College, Khuzdar, Pakistan
Dr. Ayesha Bahadur
Postgraduate Resident, Medicine Unit II, Sandeman Provincial Hospital, Quetta, Pakistan
Dr. Musarat Javed
Assistant Professor, Department of Medicine Unit IV, Bolan Medical Complex Hospital, Quetta, Pakistan
Sana Ullah Kakar
Balochistan Institute of Psychiatry and Behavioral Sciences (BIPBS), Quetta, Pakistan